- Home
- BLDR vs PTGX Comparison
BLDR vs PTGX Comparison
Compare BLDR & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLDR | PTGX |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 6.4B |
| IPO Year | 2005 | 2016 |
Fundamental Metrics
Financial Performance| Metric | BLDR | PTGX |
|---|---|---|
| Price | $74.84 | $94.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 13 |
| Target Price | ★ $121.76 | $108.23 |
| AVG Volume (30 Days) | ★ 2.4M | 469.1K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | ★ $15,190,638,000.00 | N/A |
| Revenue This Year | $0.71 | $874.25 |
| Revenue Next Year | $4.52 | N/A |
| P/E Ratio | ★ N/A | $1,864.60 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $65.10 | $49.86 |
| 52 Week High | $151.03 | $107.84 |
Technical Indicators
Market Signals| Indicator | BLDR | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 44.56 | 39.72 |
| Support Level | $65.10 | $90.58 |
| Resistance Level | $79.82 | $98.27 |
| Average True Range (ATR) | 3.26 | 3.75 |
| MACD | 0.77 | -0.90 |
| Stochastic Oscillator | 62.81 | 8.17 |
Price Performance
Historical ComparisonAbout BLDR Builders FirstSource Inc.
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.